Drug-labels.com

J07 Vaccines

ATC class of level 2 – therapeutic subgroup

This page lists the patient medication information or the product monograph for 119 drugs in this drug class and its subclasses.

Place in the ATC system

  1. J Antiinfectives for systemic use 1,101 drugs
    1. J07 Vaccines 119 drugs
      1. J07A Bacterial vaccines 29 drugs
      2. J07B Viral vaccines 78 drugs
      3. J07C Bacterial and viral vaccines, combined 12 drugs

The most common active ingredients of the class

… and 113 other active ingredients in fewer drugs.

Drugs in the class and its subclasses

DrugRx or OTC
Abrysvo PM (J07BX05 Respiratory syncytial virus vaccine) –
ACAM2000 PM (J07BX01 Smallpox and mpox vaccines) –
Act-Hib (J07AG01 Hemophilus influenzae b, purified antig. conjugated) –
Actacel PM (J07AG52 Hemophilus influenzae b, combinations with pertussis and toxoids) –
Actacel Hybrid (J07AG52 Hemophilus influenzae b, combinations with pertussis and toxoids) –
Adacel (J07AJ52 Pertussis, purified antigen, comb. with toxoids) –
Adacel-Polio PM (J07CA02 Diphtheria-pertussis-poliomyelitis-tetanus) –
Afluria Tetra PM (J07BB02 Influenza, inactivated, split virus or surface antigen) –
Agriflu PM (J07BB02 Influenza, inactivated, split virus or surface antigen) –
Arepanrix H5N1 PM (J07BB02 Influenza, inactivated, split virus or surface antigen) –
Arexvy PM (J07BX05 Respiratory syncytial virus vaccine) –
Avaxim PM (J07BC02 Hepatitis A, inactivated, whole virus) –
Avaxim - Pediatric (J07BC02 Hepatitis A, inactivated, whole virus) –
Avaxim - Pediatric -(5mL Vial) PM (J07BC02 Hepatitis A, inactivated, whole virus) –
Bexsero PM (J07AH09 Meningococcus b, multicomponent vaccine) –
Biothrax PM (J07AC01 Anthrax antigen) –
Boostrix-Polio PM (J07CA02 Diphtheria-pertussis-poliomyelitis-tetanus) –
Capvaxive PM (J07AL02 Pneumococcus, purified polysacc.antigen conjugated) –
Cervarix (J07BM02 Papillomavirus (human types 16,18)) –
Comirnaty (Biontech Manufacturing, PM 00069992) PM (J07BN01 COVID-19, rna-based vaccine) –
Comirnaty (Biontech Manufacturing, PM 00086127) PM (J07BN01 COVID-19, rna-based vaccine) –
Comirnaty Omicron Xbb.1.5 PM (J07BN01 COVID-19, rna-based vaccine) prescription (Rx)
Comirnaty Original & Omicron Ba.4/Ba.5 PM (J07BN01 COVID-19, rna-based vaccine) –
Comirnaty Original/Omicron Ba.1 PM (J07BN01 COVID-19, rna-based vaccine) –
Covifenz PM (J07BN04 COVID-19, protein subunit) –
Covishield PM (J07BN02 COVID-19, viral vector, non-replicating) –
Dukoral PM (J07AE01 Cholera, inactivated, whole cell) –
Engerix-B (Glaxosmithkline, 10 mcg, 20 mcg) PM (J07BC01 Hepatitis B, purified antigen) –
Engerix-B (Glaxosmithkline, 20 mcg, 10 mcg) PM (J07BC01 Hepatitis B, purified antigen) –
Ervebo (J07BX02 Ebola vaccines) –
Fluad (J07BB02 Influenza, inactivated, split virus or surface antigen) –
Flucelvax PM (J07BB02 Influenza, inactivated, split virus or surface antigen) –
Flucelvax Quad PM (J07BB02 Influenza, inactivated, split virus or surface antigen) –
Flulaval Tetra PM (J07BB02 Influenza, inactivated, split virus or surface antigen) –
Flumist PM (J07BB03 Influenza, live attenuated) –
Flumist Quadrivalent PM (J07BB03 Influenza, live attenuated) –
Fluviral (Id Biomedical Corporation of Quebec, PM 00053162) PM (J07BB01 Influenza, inactivated, whole virus) –
Fluviral (Id Biomedical Corporation of Quebec, PM 00085961) PM (J07BB02 Influenza, inactivated, split virus or surface antigen) –
Fluzone (Sanofi Pasteur) PM (J07BB02 Influenza, inactivated, split virus or surface antigen) –
Fluzone (Sanofi Vaccines Canada) PM (J07BB02 Influenza, inactivated, split virus or surface antigen) –
Fluzone High-Dose (J07BB02 Influenza, inactivated, split virus or surface antigen) –
Fluzone High-Dose Quadrivalent PM (J07BB02 Influenza, inactivated, split virus or surface antigen) –
Fluzone Quadrivalent (Sanofi Vaccines Canada, 15 mcg / 15 mcg / 15 mcg / 15 mcg, 30 mcg / 30 mcg / 30 mcg / 30 mcg) PM (J07BB02 Influenza, inactivated, split virus or surface antigen) –
Fluzone Quadrivalent (Sanofi Vaccines Canada, 7.5 mcg / 7.5 mcg / 7.5 mcg / 7.5 mcg, 15 mcg / 15 mcg / 15 mcg / 15 mcg) PM (J07BB02 Influenza, inactivated, split virus or surface antigen) –
Foclivia PM (J07BB02 Influenza, inactivated, split virus or surface antigen) –
Fsme-Immun (J07BA01 Encephalitis, tick borne, inactivated, whole virus) –
Gardasil PM (J07BM01 Papillomavirus (human types 6,11,16,18)) –
Gardasil 9 PM (J07BM03 Papillomavirus (human types 6,11,16,18,31,33,45,52,58)) –
Havrix 1440 (J07BC02 Hepatitis A, inactivated, whole virus) –
Hiberix PM (J07AG51 Hemophilus influenzae b, combinations with toxoids) –
Imovax Polio PM (J07BF03 Poliomyelitis, trivalent, inactivated, whole virus) –
Imovax Rabies PM (J07BG01 Rabies, inactivated, whole virus) –
Imvamune (J07BX01 Smallpox and mpox vaccines) –
Infanrix Hexa PM (J07CA02 Diphtheria-pertussis-poliomyelitis-tetanus) –
Infanrix-Ipv PM (J07CA02 Diphtheria-pertussis-poliomyelitis-tetanus) –
Infanrix-Ipv/Hib PM (J07CA06 Dipht-hemoph influen b-pertuss-polio-tetanus) –
Influenza A (H1N1) 2009 Pandemic Monovalent Vaccine (Without Adjuvant) PM (J07BB02 Influenza, inactivated, split virus or surface antigen) –
Influvac PM (J07BB01 Influenza, inactivated, whole virus) –
Influvac Tetra (J07BB02 Influenza, inactivated, split virus or surface antigen) –
Intanza PM (J07BB02 Influenza, inactivated, split virus or surface antigen) –
Ixchiq PM (J07BP01 Chikungunya, live attenuated) –
Ixiaro PM (J07BA02 Encephalitis, japanese, inactivated, whole virus) –
Jcovden (J07BN02 COVID-19, viral vector, non-replicating) –
M-M-R II PM (J07BD52 Measles, combin. with mumps and rubella, live attenuated) –
Menactra PM (J07AH08 Meningococcus, a, c, y, W-135, tetraval. purified polysacc. antigen conjugated) –
Menomune-A/C/Y/W-135 PM (J07AH04 Meningococcus, a, c, y, W-135, tetraval. purified polysacc. antigen) –
Menquadfi (J07AH08 Meningococcus, a, c, y, W-135, tetraval. purified polysacc. antigen conjugated) –
Menveo PM (J07AH08 Meningococcus, a, c, y, W-135, tetraval. purified polysacc. antigen conjugated) –
Mnexspike PM (J07BN01 COVID-19, rna-based vaccine) –
Mresvia PM (J07BX05 Respiratory syncytial virus vaccine) –
Neisvac-C (J07AH07 Meningococcus c, purified polysaccharides antigen conjugated) –
Nimenrix PM (J07AH04 Meningococcus, a, c, y, W-135, tetraval. purified polysacc. antigen) –
Nuvaxovid (Novavax) PM (J07BN04 COVID-19, protein subunit) –
Nuvaxovid (Sanofi Vaccines Canada) PM (J07BN04 COVID-19, protein subunit) –
Panenza PM (J07BB02 Influenza, inactivated, split virus or surface antigen) –
Pediacel PM (J07CA06 Dipht-hemoph influen b-pertuss-polio-tetanus) –
Pentacel (Sanofi Vaccines Canada, Liquid, Powder For Solution) PM (J07CA06 Dipht-hemoph influen b-pertuss-polio-tetanus) –
Pentacel (Sanofi Vaccines Canada, Suspension) PM (J07CA06 Dipht-hemoph influen b-pertuss-polio-tetanus) –
Pneumovax 23 -(5-Dose) PM (J07AL02 Pneumococcus, purified polysacc.antigen conjugated) –
Pneumovax 23 (Merck Canada, PM 00035855) PM (J07AL02 Pneumococcus, purified polysacc.antigen conjugated) –
Pneumovax 23 (Merck Canada, PM 00075041) PM (J07AL01 Pneumococcus, purified polysaccharides antigen) –
Prehevbrio PM (J07BC01 Hepatitis B, purified antigen) –
Prevnar 13 PM (J07AL02 Pneumococcus, purified polysacc.antigen conjugated) –
Prevnar 20 PM (J07AL02 Pneumococcus, purified polysacc.antigen conjugated) –
Priorix PM (J07BD52 Measles, combin. with mumps and rubella, live attenuated) –
Priorix-Tetra (J07BD54 Measles, combinations with mumps, rubella and varicella, live attenuated) –
Proquad (J07BD54 Measles, combinations with mumps, rubella and varicella, live attenuated) –
Quadracel (Sanofi Vaccines Canada, 15 Lf / 5 Lf / 20 mcg / 20 mcg / 3 mc...) PM (J07CA02 Diphtheria-pertussis-poliomyelitis-tetanus) –
Quadracel (Sanofi Vaccines Canada, 20 mcg / 20 mcg / 5 mcg / 3 mcg / 15...) PM (J07CA02 Diphtheria-pertussis-poliomyelitis-tetanus) –
Rabavert PM (J07BG01 Rabies, inactivated, whole virus) –
Recombivax Hb PM (J07BC01 Hepatitis B, purified antigen) –
Recombivax Hb (with Preservative) PM (J07BC01 Hepatitis B, purified antigen) –
Rotarix PM (J07BH01 Rota virus, live attenuated) –
Rotateq PM (J07BH02 Rota virus, pentavalent, live, reassorted) –
Spikevax (Moderna Biopharma Canada, 0.1 mg, 50 mcg, 25 mcg) PM (J07BN01 COVID-19, rna-based vaccine) –
Spikevax (Moderna Biopharma Canada, 0.2 mg, 0.1 mg) PM (J07BN01 COVID-19, rna-based vaccine) –
Spikevax Bivalent PM (J07BN01 COVID-19, rna-based vaccine) –
Spikevax Bivalent (Original / Omicron Ba.4/5) PM (J07BN01 COVID-19, rna-based vaccine) –
Supemtek (J07BB02 Influenza, inactivated, split virus or surface antigen) –
Synflorix PM (J07AL02 Pneumococcus, purified polysacc.antigen conjugated) –

Other classes of the same level

Other names of the drug class

Sources

  • Patient medication information and product monographs: Health Canada, Drug Product Database
  • Active ingredients, ATC codes and Rx or OTC status: Health Canada, Drug Product Database
  • World Health Organization (WHO): ATC/DDD system, class J07

Ask your doctor or pharmacist for advice.